Hyundai Pharmaceutical Co., Ltd. (004310.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 95.79B |
| Enterprise Value | 143.35B |
| P/E Ratio | 55.36 |
| PEG Ratio | 0.26 |
| Price/Sales Ratio | 1 |
| Price/Book Ratio | 1.6 |
| Enterprise/Revenue | 1.18 |
| Enterprise/EBITDA | 23.48 |
Fiscal Year
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | August 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 191.79B |
| Revenue/Share | 6,696.9 |
| Gross Profit | 78.23B |
| EBITDA | 7.58B |
| Net Income | 2.52B |
| Diluted EPS | 96.28 |
Balance Sheet
| Total Cash | 22.72B |
| Total Cash/Share | 735.05 |
| Total Debt | 49.54B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 1.7 |
| Book Value Per Share | 4,208.45 |
Price History
| 52-Week Change | 84.3 |
| 52-Week High | 15,960 |
| 52-Week Low | 3,500 |
| Moving Average 50 Days | 8,021 |
| Moving Average 200 Days | 8,230.7 |
Statistics
| Average Volume | 4.08M |
| Shares Outstanding | 30.92M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 30 |
| Trailing Annual Dividend Yield | 0.45 |
| Payout Ratio | 0.26 |
| Last Split Factor | 513:500 |
| Last Split Date | October 20, 2017 |
AD
